Celtics, the two new streams of revenue tell an incredible story. What I see happening with today's PR is the beginning of Mr. Schneiderman expanding the already successful SCRC business model to that of a compounding pharmacy conglomerate. And believe me, there are large corporate eyes watching every step of this developing megastar of a company. I've always said MAP was limited in the volume they could achieve by it's number of staff. Now, with the United Apothecary, the revenue volume can grow beyond our expectations. Not only that with PIMD supplying the ingredients, it's a one-two punch for success. Not to mention with all this excitement today, we still have Rapimeds looming in the background. When Mr. Schneiderman achieves the impact of RapiMeds to the bottom line he believes it will, there is no reason we couldn't be looking at a company with a $100M annual run rate. Along with that, I see the decimal moving one position to the right with the pps from .10 to 1.00.

By the way, I really like the term apothecary. Years ago all pharmacies were called apothecaries. Compound pharmacies are not new. Apothecaries were actually the first compounding pharmacies. Years ago they made all the medicines, combining all the ingredients to make pills, capsules, suppositories, solutions, etc. With the entry of major pharma companies, the apothecaries went along the wayside, but never died. History is definitely repeating itself.